id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-300964-knc0ruou	Hoffman, Tove	Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2	2020-04-14		.txt	text/plain	2546	139	54	We evaluated a commercially available test developed for rapid (within 15 minutes) detection of SARS-CoV-2-specific IgM and IgG by 29 PCR-confirmed COVID-19 cases and 124 negative controls. In the present study, we evaluated a commercially available assay, the COVID-19 IgG/IgM Rapid Test Cassette (Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China), developed for detection of SARS-CoV-2-specific antibodies. None of the 24 healthy volunteers, without any known history of SARS-CoV-2 infection/COVID-19, tested positive for IgM or IgG. In this study we evaluated a commercial rapid test for detection of SARS-CoV-2-specific IgM and IgG. If this was the case for one or more of the included patients, the actual sensitivities should be higher, i.e. when evaluated only on samples known to contain detectable levels of SARS-CoV-2-specific IgM and/or IgG. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis	./cache/cord-300964-knc0ruou.txt	./txt/cord-300964-knc0ruou.txt